Prevalence of multiple myeloma

Study type

• Study topic:
  Disease /health condition
• Study type:
  Non-interventional study
• Scope of the study:
  Disease epidemiology
• Data collection methods:
  Secondary data collection

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Descriptive study

Study drug and medical condition

• Medical condition to be studied:
  Plasma cell myeloma

Population studied

• Short description of the study population:
  The study included patients with at least one encounter (consultation, prescription) to determine the prevalence of multiple myeloma, between 2015 and 2020, identified from the IMRD databases.
• Age groups:
  Children (2 to < 12 years)

  Adolescents (12 to < 18 years)

  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Special population of interest:
  Other
• Special population of interest, other:
  Multiple Myeloma patients
• Estimated number of subjects:
  10000

Study design details

• Main study objective:
  to determine the complete prevalence of Multiple Myeloma in electronic health records of three European countries (France, Germany, United Kingdom).
• Data analysis plan:
  Prevalence was determined using the any-time method. The denominator was calculated as the count of patients of all ages who are eligible, i.e. had at least one observation (consultation or prescription), during the period of interest. The numerator was computed as the count of patients that had at least one code for Multiple Myeloma, per a list of pre-selected codes, during the period starting from the start of data collection for the patient to the end of the period of interest (i.e. complete prevalence). Results were not stratified by age or gender.

Documents

Study results

Multiple Myeloma Prevalence Report - 20220513 - To be published_CLEAN